| 92 | Humans (MeSH) |
| 42 | SARS-CoV-2 (MeSH) |
| 40 | COVID-19 (MeSH) |
| 38 | Animals (MeSH) |
| 36 | COVID-19 (immunology) |
| 33 | Pandemics (MeSH) |
| 30 | Female (MeSH) |
| 27 | Male (MeSH) |
| 24 | Coronavirus Infections (immunology) |
| 22 | Pneumonia, Viral (immunology) |
| 19 | SARS-CoV-2 (immunology) |
| 17 | Middle Aged (MeSH) |
| 16 | Immunity, Mucosal (MeSH) |
| 16 | Betacoronavirus (immunology) |
| 14 | Pneumonia, Viral (virology) |
| 14 | Coronavirus Infections (prevention & control) |
| 14 | COVID-19 (virology) |
| 14 | COVID-19 (prevention & control) |
| 13 | Coronavirus Infections (virology) |
| 13 | Aged (MeSH) |
| 12 | Respiratory Mucosa (immunology) |
| 12 | COVID-19 Vaccines (MeSH) |
| 12 | Adult (MeSH) |
| 11 | Spike Glycoprotein, Coronavirus (immunology) |
| 11 | Mice (MeSH) |
| 11 | Lung (immunology) |
| 11 | Immunity, Innate (MeSH) |
| 11 | Antibodies, Viral (immunology) |
| 10 | Respiratory Mucosa (virology) |
| 10 | Child (MeSH) |
| 10 | COVID-19 (pathology) |
| 10 | Antibodies, Viral (blood) |
| 9 | Betacoronavirus (MeSH) |
| 9 | Antibodies, Neutralizing (immunology) |
| 8 | Viral Vaccines (immunology) |
| 8 | Severity of Illness Index (MeSH) |
| 8 | Serine Endopeptidases (metabolism) |
| 8 | Pneumonia, Viral (prevention & control) |
| 8 | Pandemics (prevention & control) |
| 8 | Nasal Mucosa (immunology) |
| 7 | Young Adult (MeSH) |
| 7 | Viral Vaccines (administration & dosage) |
| 7 | Spike Glycoprotein, Coronavirus (genetics) |
| 7 | SARS-CoV-2 (physiology) |
| 7 | Pneumonia, Viral (pathology) |
| 7 | Pneumonia, Viral (epidemiology) |
| 7 | Nasal Mucosa (virology) |
| 7 | Lung (virology) |
| 7 | Immunoglobulin A (immunology) |
| 7 | Disease Models, Animal (MeSH) |
| 7 | Coronavirus Infections (pathology) |
| 7 | Coronavirus Infections (epidemiology) |
| 7 | COVID-19 (genetics) |
| 7 | Betacoronavirus (physiology) |
| 7 | Antibodies, Neutralizing (blood) |
| 7 | Angiotensin-Converting Enzyme 2 (MeSH) |
| 6 | Viral Load (MeSH) |
| 6 | T-Lymphocytes (immunology) |
| 6 | SARS-CoV-2 (pathogenicity) |
| 6 | Respiratory Mucosa (metabolism) |
| 6 | Peptidyl-Dipeptidase A (metabolism) |
| 6 | Mucosal-Associated Invariant T Cells (immunology) |
| 6 | Lung (pathology) |
| 6 | Immunity, Mucosal (immunology) |
| 6 | Immunity, Innate (immunology) |
| 6 | Child, Preschool (MeSH) |
| 6 | COVID-19 Vaccines (immunology) |
| 6 | COVID-19 (physiopathology) |
| 6 | Antiviral Agents (therapeutic use) |
| 6 | Adolescent (MeSH) |
| 5 | Virus Replication (MeSH) |
| 5 | Virus Internalization (MeSH) |
| 5 | Vero Cells (MeSH) |
| 5 | Vaccination (MeSH) |
| 5 | Pneumonia, Viral (complications) |
| 5 | Immunologic Memory (MeSH) |
| 5 | Immunoglobulin G (blood) |
| 5 | Immunoglobulin A (blood) |
| 5 | Immunity, Humoral (MeSH) |
| 5 | Coronavirus Infections (therapy) |
| 5 | Coronavirus Infections (drug therapy) |
| 5 | Coronavirus Infections (complications) |
| 5 | Chlorocebus aethiops (MeSH) |
| 5 | Cell Line (MeSH) |
| 5 | COVID-19 Vaccines (administration & dosage) |
| 5 | COVID-19 (complications) |
| 5 | Antiviral Agents (pharmacology) |
| 5 | Angiotensin-Converting Enzyme 2 (metabolism) |
| 5 | Aged, 80 and over (MeSH) |
| 4 | Severe Acute Respiratory Syndrome (immunology) |
| 4 | Serine Endopeptidases (genetics) |
| 4 | SARS-CoV-2 (drug effects) |
| 4 | Risk Factors (MeSH) |
| 4 | Respiratory Mucosa (pathology) |
| 4 | Respiratory Mucosa (drug effects) |
| 4 | Pneumonia, Viral (therapy) |
| 4 | Pneumonia, Viral (physiopathology) |
| 4 | Pneumonia, Viral (drug therapy) |
| 4 | Neoplasms (immunology) |
| 4 | Intestinal Mucosa (immunology) |
| 4 | Interleukin-17 (metabolism) |
| 4 | Infant, Newborn (MeSH) |
| 4 | Infant (MeSH) |
| 4 | Immunoglobulin G (immunology) |
| 4 | Immunity, Cellular (MeSH) |
| 4 | Host-Pathogen Interactions (MeSH) |
| 4 | Cytokines (metabolism) |
| 4 | Coronavirus Infections (physiopathology) |
| 4 | Cells, Cultured (MeSH) |
| 4 | Case-Control Studies (MeSH) |
| 4 | COVID-19 (metabolism) |
| 4 | COVID-19 (epidemiology) |
| 4 | COVID-19 (diagnosis) |
| 4 | COVID-19 (blood) |
| 3 | Viral Vaccines (supply & distribution) |
| 3 | Viral Tropism (MeSH) |
| 3 | Signal Transduction (MeSH) |
| 3 | SARS-CoV-2 (metabolism) |
| 3 | SARS-CoV-2 (genetics) |
| 3 | SARS Virus (immunology) |
| 3 | Retrospective Studies (MeSH) |
| 3 | Respiratory Mucosa (cytology) |
| 3 | Pneumonia, Viral (transmission) |
| 3 | Pneumonia, Viral (metabolism) |
| 3 | Peptidyl-Dipeptidase A (genetics) |
| 3 | Pathogen-Associated Molecular Pattern Molecules (immunology) |
| 3 | Mucosal-Associated Invariant T Cells (metabolism) |
| 3 | Mice, Inbred BALB C (MeSH) |
| 3 | Macaca mulatta (MeSH) |
| 3 | Intestinal Mucosa (virology) |
| 3 | Intestinal Mucosa (metabolism) |
| 3 | Interleukin-6 (immunology) |
| 3 | Influenza, Human (immunology) |
| 3 | Immunogenicity, Vaccine (MeSH) |
| 3 | Host-Pathogen Interactions (immunology) |
| 3 | HEK293 Cells (MeSH) |
| 3 | Gastrointestinal Microbiome (MeSH) |
| 3 | Drug Industry (MeSH) |
| 3 | Coronavirus Infections (transmission) |
| 3 | Coronavirus Infections (metabolism) |
| 3 | Clinical Trials as Topic (MeSH) |
| 3 | COVID-19 (transmission) |
| 3 | COVID-19 (therapy) |
| 3 | Bronchoalveolar Lavage Fluid (virology) |
| 3 | Betacoronavirus (pathogenicity) |
| 3 | Betacoronavirus (drug effects) |
| 3 | Asymptomatic Infections (MeSH) |
| 3 | Angiotensin-Converting Enzyme 2 (genetics) |
| 3 | Administration, Intranasal (methods) |
| 3 | Administration, Intranasal (MeSH) |
| 3 | Adenoviridae (genetics) |
| 2 | Virus Shedding (MeSH) |
| 2 | Virus Replication (physiology) |
| 2 | Virus Replication (immunology) |
| 2 | Virus Diseases (prevention & control) |
| 2 | Virus Attachment (drug effects) |
| 2 | Viral Vaccines (biosynthesis) |
| 2 | Up-Regulation (MeSH) |
| 2 | Transcriptome (MeSH) |
| 2 | Time Factors (MeSH) |
| 2 | T-Lymphocytes (metabolism) |
| 2 | Symptom Assessment (MeSH) |
| 2 | Spike Glycoprotein, Coronavirus (chemistry) |
| 2 | Single-Cell Analysis (MeSH) |
| 2 | Severe Acute Respiratory Syndrome (therapy) |
| 2 | SARS-CoV-2 (isolation & purification) |
| 2 | Respiratory Tract Infections (microbiology) |
| 2 | Respiratory System (virology) |
| 2 | Respiratory System (immunology) |
| 2 | Respiratory Mucosa (physiopathology) |
| 2 | Receptors, Virus (genetics) |
| 2 | Receptors, Coronavirus (metabolism) |
| 2 | Protein Domains (MeSH) |
| 2 | Protein Binding (MeSH) |
| 2 | Probiotics (MeSH) |
| 2 | Pneumonia, Viral (genetics) |
| 2 | Plasma Cells (immunology) |
| 2 | Phosphoproteins (immunology) |
| 2 | Personal Protective Equipment (MeSH) |
| 2 | Pathogen-Associated Molecular Pattern Molecules (metabolism) |
| 2 | Organoids (virology) |
| 2 | Olfactory Mucosa (metabolism) |
| 2 | Olfactory Mucosa (immunology) |
| 2 | Neutralization Tests (MeSH) |
| 2 | Nasal Mucosa (drug effects) |
| 2 | Nasal Mucosa (cytology) |
| 2 | Myeloid Cells (pathology) |
| 2 | Mycobacterium tuberculosis (MeSH) |
| 2 | Mutation (MeSH) |
| 2 | Mucin 5AC (metabolism) |
| 2 | Mouth Mucosa (immunology) |
| 2 | Models, Biological (MeSH) |
| 2 | Models, Animal (MeSH) |
| 2 | Middle East Respiratory Syndrome Coronavirus (immunology) |
| 2 | Mice, Inbred C57BL (MeSH) |
| 2 | Madin Darby Canine Kidney Cells (MeSH) |
| 2 | Macrophages (immunology) |
| 2 | Lymphoid Tissue (immunology) |
| 2 | Lymphocyte Activation (immunology) |
| 2 | Lymphocyte Activation (MeSH) |
| 2 | Lung (metabolism) |
| 2 | Lung (cytology) |
| 2 | Longitudinal Studies (MeSH) |
| 2 | Intestinal Mucosa (cytology) |
| 2 | Interleukins (immunology) |
| 2 | Interleukin-1beta (immunology) |
| 2 | Interferon Type I (immunology) |
| 2 | Influenza A virus (immunology) |
| 2 | Inflammatory Bowel Diseases (immunology) |
| 2 | Inflammatory Bowel Diseases (complications) |
| 2 | Inflammation (virology) |
| 2 | Inflammation (pathology) |
| 2 | Inflammation (immunology) |
| 2 | Immunologic Memory (immunology) |
| 2 | Immunoglobulin M (blood) |
| 2 | Immunoglobulin A (metabolism) |
| 2 | Immunization, Secondary (MeSH) |
| 2 | Immunity, Innate (genetics) |
| 2 | Immunity, Innate (drug effects) |
| 2 | Immunity (immunology) |
| 2 | Immunity (MeSH) |
| 2 | Immune Evasion (MeSH) |
| 2 | Homeostasis (MeSH) |
| 2 | Goblet Cells (metabolism) |
| 2 | Genetic Vectors (MeSH) |
| 2 | Gene Regulatory Networks (MeSH) |
| 2 | Gene Expression Regulation (MeSH) |
| 2 | Gastrointestinal Tract (microbiology) |
| 2 | Epithelial Cells (virology) |
| 2 | Enzyme-Linked Immunosorbent Assay (MeSH) |
| 2 | Dogs (MeSH) |
| 2 | Diet (MeSH) |
| 2 | Cytokines (immunology) |
| 2 | Cytokines (blood) |
| 2 | Cytokine Release Syndrome (immunology) |
| 2 | Cricetinae (MeSH) |
| 2 | Coronavirus Infections (genetics) |
| 2 | Comorbidity (MeSH) |
| 2 | Cohort Studies (MeSH) |
| 2 | Cell Line, Tumor (MeSH) |
| 2 | Caco-2 Cells (MeSH) |
| 2 | COVID-19 (mortality) |
| 2 | COVID-19 (drug therapy) |
| 2 | Bronchi (virology) |
| 2 | Bronchi (metabolism) |
| 2 | Bronchi (cytology) |
| 2 | Binding Sites (MeSH) |
| 2 | Betacoronavirus (metabolism) |
| 2 | Betacoronavirus (isolation & purification) |
| 2 | Betacoronavirus (growth & development) |
| 2 | Betacoronavirus (genetics) |
| 2 | B-Lymphocytes (immunology) |
| 2 | Antiviral Agents (chemical synthesis) |
| 2 | Antibodies, Viral (analysis) |
| 2 | Antibodies, Neutralizing (analysis) |
| 2 | Antibodies, Monoclonal (immunology) |
| 2 | Alveolar Epithelial Cells (metabolism) |
| 2 | Administration, Oral (MeSH) |
| 2 | Adaptive Immunity (MeSH) |
| 1 | Zinc (metabolism) |
| 1 | Zika Virus (MeSH) |
| 1 | Water (MeSH) |
| 1 | Vomiting (physiopathology) |
| 1 | Vitamin D (physiology) |
| 1 | Viruses (isolation & purification) |
| 1 | Virus Replication (genetics) |
| 1 | Virus Internalization (drug effects) |
| 1 | Virus Diseases (transmission) |
| 1 | Virus Diseases (therapy) |
| 1 | Virus Diseases (microbiology) |
| 1 | Virus Diseases (immunology) |
| 1 | Virus Diseases (epidemiology) |
| 1 | Virus Diseases (diagnosis) |
| 1 | Virus Cultivation (MeSH) |
| 1 | Virulence (MeSH) |
| 1 | Virome (physiology) |
| 1 | Virology (MeSH) |
| 1 | Virion (physiology) |
| 1 | Virion (pathogenicity) |
| 1 | Virion (chemistry) |
| 1 | Viral Vaccines (therapeutic use) |
| 1 | Viral Vaccines (standards) |
| 1 | Viral Vaccines (pharmacology) |
| 1 | Viral Vaccines (genetics) |
| 1 | Viral Vaccines (economics) |
| 1 | Viral Vaccines (chemistry) |
| 1 | Viral Vaccines (adverse effects) |
| 1 | Viral Tropism (physiology) |
| 1 | Vaccinia virus (immunology) |
| 1 | Vaccines, Synthetic (administration & dosage) |
| 1 | Vaccines, Subunit (administration & dosage) |
| 1 | Vaccines, DNA (immunology) |
| 1 | Vaccines, DNA (administration & dosage) |
| 1 | Vaccines, DNA (MeSH) |
| 1 | Vaccines, Attenuated (immunology) |
| 1 | Vaccines (immunology) |
| 1 | Uncertainty (MeSH) |
| 1 | Tumor Necrosis Factor-alpha (metabolism) |
| 1 | Tuberculosis, Pulmonary (prevention & control) |
| 1 | Tuberculosis, Pulmonary (microbiology) |
| 1 | Tuberculosis, Pulmonary (immunology) |
| 1 | Tuberculosis (immunology) |
| 1 | Treatment Outcome (MeSH) |
| 1 | Transforming Growth Factor beta (immunology) |
| 1 | Transcriptome (genetics) |
| 1 | Trachea (virology) |
| 1 | Toll-Like Receptor 4 (immunology) |
| 1 | Tissue Culture Techniques (MeSH) |
| 1 | Thalamus (MeSH) |
| 1 | Th2 Cells (physiology) |
| 1 | Th1 Cells (immunology) |
| 1 | Telemedicine (MeSH) |
| 1 | Taste (genetics) |
| 1 | TOR Serine-Threonine Kinases (immunology) |
| 1 | TOR Serine-Threonine Kinases (genetics) |
| 1 | T-Lymphocytes (transplantation) |
| 1 | T-Lymphocytes (pathology) |
| 1 | T-Lymphocytes (cytology) |
| 1 | T-Lymphocyte Subsets (immunology) |
| 1 | Systemic Inflammatory Response Syndrome (physiopathology) |
| 1 | Systemic Inflammatory Response Syndrome (pathology) |
| 1 | Systemic Inflammatory Response Syndrome (metabolism) |
| 1 | Systemic Inflammatory Response Syndrome (immunology) |
| 1 | Systemic Inflammatory Response Syndrome (etiology) |
| 1 | Systemic Inflammatory Response Syndrome (epidemiology) |
| 1 | Systemic Inflammatory Response Syndrome (blood) |
| 1 | Steroid Hydroxylases (pharmacology) |
| 1 | Stem Cells (virology) |
| 1 | Sputum (virology) |
| 1 | Spike Glycoprotein, Coronavirus (metabolism) |
| 1 | Spike Glycoprotein, Coronavirus (biosynthesis) |
| 1 | Spike Glycoprotein, Coronavirus (MeSH) |
| 1 | Species Specificity (MeSH) |
| 1 | Societies, Scientific (organization & administration) |
| 1 | Societies, Scientific (MeSH) |
| 1 | Smoking (adverse effects) |
| 1 | Smell (MeSH) |
| 1 | Severe Acute Respiratory Syndrome (virology) |
| 1 | Severe Acute Respiratory Syndrome (physiopathology) |
| 1 | Severe Acute Respiratory Syndrome (pathology) |
| 1 | Severe Acute Respiratory Syndrome (epidemiology) |
| 1 | Serologic Tests (methods) |
| 1 | Serine Endopeptidases (immunology) |
| 1 | Serine Endopeptidases (biosynthesis) |
| 1 | Sensitivity and Specificity (MeSH) |
| 1 | Sendai virus (genetics) |
| 1 | Secondary Metabolism (MeSH) |
| 1 | Saliva (virology) |
| 1 | Saliva (immunology) |
| 1 | Saccharomyces cerevisiae (MeSH) |
| 1 | SARS-CoV-2 (chemistry) |
| 1 | SARS Virus (pathogenicity) |
| 1 | SARS Virus (drug effects) |
| 1 | SARS Virus (MeSH) |
| 1 | Reverse Genetics (methods) |
| 1 | Respiratory Tract Infections (virology) |
| 1 | Respiratory Tract Infections (immunology) |
| 1 | Respiratory Tract Infections (epidemiology) |
| 1 | Respiratory Tract Infections (diagnosis) |
| 1 | Respiratory Tract Infections (MeSH) |
| 1 | Respiratory Tract Absorption (MeSH) |
| 1 | Respiratory System (physiopathology) |
| 1 | Respiratory System (pathology) |
| 1 | Respiratory Syncytial Viruses (immunology) |
| 1 | Respiratory Syncytial Viruses (MeSH) |
| 1 | Respiratory Syncytial Virus Infections (immunology) |
| 1 | Respiratory Mucosa (microbiology) |
| 1 | Respiratory Mucosa (blood supply) |
| 1 | Respiratory Mucosa (MeSH) |
| 1 | Respiration, Artificial (methods) |
| 1 | Reinfection (immunology) |
| 1 | Recurrence (MeSH) |
| 1 | Receptors, Virus (metabolism) |
| 1 | Receptors, Interferon (analysis) |
| 1 | Receptors, G-Protein-Coupled (genetics) |
| 1 | Receptors, CXCR3 (metabolism) |
| 1 | Receptors, Antigen, T-Cell (MeSH) |
| 1 | Reactive Oxygen Species (metabolism) |
| 1 | Rats (MeSH) |
| 1 | Rabbits (MeSH) |
| 1 | RNA-Seq (MeSH) |
| 1 | RNA, Viral (genetics) |
| 1 | RNA, Viral (MeSH) |
| 1 | RNA (genetics) |
| 1 | Pulmonary Alveoli (virology) |
| 1 | Pulmonary Alveoli (metabolism) |
| 1 | Psoriasis (epidemiology) |
| 1 | Proto-Oncogene Proteins c-akt (immunology) |
| 1 | Proto-Oncogene Proteins c-akt (genetics) |
| 1 | Protein Structure, Tertiary (MeSH) |
| 1 | Protein Structure, Secondary (MeSH) |
| 1 | Protein Stability (MeSH) |
| 1 | Protein Interaction Domains and Motifs (MeSH) |
| 1 | Probiotics (therapeutic use) |
| 1 | Probiotics (metabolism) |
| 1 | Prions (MeSH) |
| 1 | Primary Immunodeficiency Diseases (microbiology) |
| 1 | Primary Immunodeficiency Diseases (epidemiology) |
| 1 | Pregnancy Complications, Infectious (virology) |
| 1 | Pregnancy Complications, Infectious (immunology) |
| 1 | Pregnancy Complications, Infectious (genetics) |
| 1 | Pregnancy (MeSH) |
| 1 | Prebiotics (MeSH) |
| 1 | Practice Guidelines as Topic (MeSH) |
| 1 | Polyphosphates (therapeutic use) |
| 1 | Polyphosphates (pharmacology) |
| 1 | Polyphosphates (metabolism) |
| 1 | Polyphenols (therapeutic use) |
| 1 | Polymorphism, Single Nucleotide (MeSH) |
| 1 | Polylactic Acid-Polyglycolic Acid Copolymer (immunology) |
| 1 | Pneumonia, Viral (microbiology) |
| 1 | Pneumonia, Viral (diagnosis) |
| 1 | Pneumonia, Viral (blood) |
| 1 | Pneumonia, Viral (MeSH) |
| 1 | Pneumonia, Bacterial (immunology) |
| 1 | Personal Protective Equipment (supply & distribution) |
| 1 | Permeability (MeSH) |
| 1 | Peptidyl-Dipeptidase A (immunology) |
| 1 | Peptidyl-Dipeptidase A (biosynthesis) |
| 1 | Patient Education as Topic (organization & administration) |
| 1 | Patient Acuity (MeSH) |
| 1 | Palatine Tonsil (immunology) |
| 1 | Palatine Tonsil (cytology) |
| 1 | Oxygen (metabolism) |
| 1 | Orthomyxoviridae Infections (immunology) |
| 1 | Organoids (immunology) |
| 1 | Organoids (drug effects) |
| 1 | Organoids (MeSH) |
| 1 | Oral Sprays (MeSH) |
| 1 | Olfactory Receptor Neurons (virology) |
| 1 | Olfactory Receptor Neurons (physiology) |
| 1 | Olfactory Receptor Neurons (metabolism) |
| 1 | Olfactory Receptor Neurons (immunology) |
| 1 | Olfactory Mucosa (virology) |
| 1 | Olfactory Mucosa (physiopathology) |
| 1 | Olfactory Mucosa (cytology) |
| 1 | Olfactory Mucosa (MeSH) |
| 1 | Olfactory Bulb (virology) |
| 1 | Olfactory Bulb (pathology) |
| 1 | Olfactory Bulb (immunology) |
| 1 | Olfaction Disorders (physiopathology) |
| 1 | Olfaction Disorders (immunology) |
| 1 | Olfaction Disorders (etiology) |
| 1 | Occupational Exposure (prevention & control) |
| 1 | Nuclear Proteins (immunology) |
| 1 | Nod2 Signaling Adaptor Protein (immunology) |
| 1 | Nod2 Signaling Adaptor Protein (genetics) |
| 1 | Neutrophils (pathology) |
| 1 | Neutralization Tests (standards) |
| 1 | Neuropilin-1 (immunology) |
| 1 | Neoplasms (therapy) |
| 1 | Neoplasms (radiotherapy) |
| 1 | Neoplasms (genetics) |
| 1 | Neoplasms (complications) |
| 1 | Nausea (physiopathology) |
| 1 | Nasal Mucosa (pathology) |
| 1 | Nasal Mucosa (metabolism) |
| 1 | Myeloid Cells (immunology) |
| 1 | Myeloid Cells (drug effects) |
| 1 | Mycobiome (physiology) |
| 1 | Mutant Proteins (immunology) |
| 1 | Mutant Proteins (chemistry) |
| 1 | Mucous Membrane (virology) |
| 1 | Mucous Membrane (metabolism) |
| 1 | Mucosal-Associated Invariant T Cells (cytology) |
| 1 | Mucin-1 (metabolism) |
| 1 | Mouth Mucosa (cytology) |
| 1 | Monocytes (immunology) |
| 1 | Models, Theoretical (MeSH) |
| 1 | Models, Molecular (MeSH) |
| 1 | Minor Histocompatibility Antigens (metabolism) |
| 1 | Middle East Respiratory Syndrome Coronavirus (physiology) |
| 1 | Middle East Respiratory Syndrome Coronavirus (drug effects) |
| 1 | Middle East Respiratory Syndrome Coronavirus (MeSH) |
| 1 | Microscopy, Electron (MeSH) |
| 1 | Microbiota (immunology) |
| 1 | MicroRNAs (metabolism) |
| 1 | MicroRNAs (genetics) |
| 1 | Mesocricetus (virology) |
| 1 | Membrane Proteins (metabolism) |
| 1 | Membrane Proteins (genetics) |
| 1 | Medicine, Chinese Traditional (MeSH) |
| 1 | Mass Screening (standards) |
| 1 | Mass Screening (methods) |
| 1 | Mass Screening (MeSH) |
| 1 | Machine Learning (MeSH) |
| 1 | Lymphocytes (immunology) |
| 1 | Lymphocyte Count (MeSH) |
| 1 | Lung Injury (immunology) |
| 1 | Lung Injury (etiology) |
| 1 | Lung Injury (diagnosis) |
| 1 | Lung Diseases, Interstitial (virology) |
| 1 | Lung Diseases, Interstitial (pathology) |
| 1 | Lung Diseases, Interstitial (immunology) |
| 1 | Lung Diseases (immunology) |
| 1 | Lung (microbiology) |
| 1 | Lung (blood supply) |
| 1 | Lung (MeSH) |
| 1 | Liver (metabolism) |
| 1 | Liver (immunology) |
